Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2024

Aktualisierungshinweis

Die DDG-Praxisempfehlungen werden regelmäßig zur zweiten Jahreshälfte aktualisiert. Bitte stellen Sie sicher, dass Sie jeweils die neueste Version lesen und zitieren.

Publication History

Article published online:
21 November 2024

• Literatur

• 1 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), (AWMF AdWMF). Nationale VersorgungsLeitlinie Typ-2-Diabetes – Langfassung. Version 3.0. 2023. 2023
• 2 Liao D, Liu C, Chen S. et al. Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus. Int Immunopharmacol 2023; 122: 110414
• 3 Chen X, Affinati AH, Lee Y. et al. Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes. Diabetes Care 2022; 45: 1170-1176
• 4 Bundesärztekammer (BÄK). Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen; Stand: 16.06.2024.
• 5 Heinemann L, Adamczewski H, Neumann C. et al. Gemeinsames Positionspapier der Kommission Labordiagnostik in der Diabetologie der DDG und DGKL und der Kommission Apotheker in der Diabetologie BAK/DDG zur Herstellung einer oGTT-Lösung für die Diagnose eines Diabetes einschließlich eines Gestationsdiabetes. Diabetologie und Stoffwechsel 2020; 15: 470-471
• 6 Krüger M, Heinemann L. Verfügbarkeit von Fertiglösungen für den oGTT: ein Update. Diabetes Stoffw Herz 2023; 23: 90-91
• 7 Heil W, Jachtmann A, Rick W. Zur Reproduzierbarkeit der Ergebnisse des oralen Glucose-Toleranz-Tests. LaboratoriumsMedizin/Journal of Laboratory Medicine 1990; 14: 440-444
• 8 Deutsche Diabetes Gesellschaft, Deutsche Gesellschaft für Gynäkologie und Geburtshilfe. S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. In: AWMF-Registernummer: 057–008. 2018
• 9 Kleinwechter H. Gestationsdiabetes mellitus – Update 2022. MMW Fortschr Med 2022; 164: 29-34
• 10 Landgraf R. HbA_1c in der Diabetesdiagnostik. Diabetes aktuell 2021; 19: 22-29
• 11 Pleus S, Heinemann L, Freckmann G. et al. Glukosemessung in der Diabetesdiagnostik und -therapie: Laboratoriumsmedizinische Untersuchung inkl. patientennaher Sofortdiagnostik, Blutglukoseselbstmessung und kontinuierliches Glukosemonitoring. Diabetol Stoffwechs 2021; 17: 52-60
• 12 Freckmann G, Heinemann L, Pleus S. et al. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland. Dtsch Med Wochenschr 2022; 147: 407-413
• 13 Magliano D, Boyko EJ. IDF diabetes atlas. 10. Aufl. Brüssel: International Diabetes Federation; 2021
• 14 Committee ADAPP. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes – 2024. Diabetes Care 2023; 47: S20-S42
• 15 Grant PJ, Cosentino F. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: New features and the „Ten Commandments“ of the 2019 Guidelines are discussed by Professor Peter J. Grant and Professor Francesco Cosentino, the Task Force chairmen. Eur Heart J 2019; 40: 3215-3217
• 16 Organization WH. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. Geneva; Switzerland: World Health Organization: 2006
• 17 Gemeinsamer Bundesausschuss. Mutterschafts-Richtlinie/Mu-RL in der Fassung vom 21. September 2023. In: zuletzt geändert am 28. September 2023 veröffentlicht im Bundesanzeiger AT 18122023 B2.
• 18 Metzger BE, Lowe LP. Group HSCR. et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002
• 19 Fischer MM, Hannemann A, Winter T. et al. Relative Efficacy of Different Strategies for Inhibition of in Vitro Glycolysis. Clin Chem 2021; 67: 1032-1034
• 20 Heinemann L, Freckmann G. Quality of HbA_1c Measurement in the Practice: The German Perspective. J Diabetes Sci Technol 2015; 9: 687-695
• 21 Heinemann L, Kaiser P, Freckmann G. et al. Higher HbA_1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany. Horm Metab Res 2018; 50: 728-734
• 22 Gough A, Sitch A, Ferris E. et al. Within-subject variation of HbA_1c: A systematic review and meta-analysis. PLoS One 2023; 18: e0289085
• 23 Pani LN, Korenda L, Meigs JB. et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care 2008; 31: 1991-1996
• 24 Roth J, Muller N, Lehmann T. et al. HbA_1c and Age in Non-Diabetic Subjects: An Ignored Association?. Exp Clin Endocrinol Diabetes 2016; 124: 637-642
• 25 Masuch A, Friedrich N, Roth J. et al. Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA_1c reference intervals derived from two population-based study cohorts. BMC Endocr Disord 2019; 19: 20
• 26 Lampasona V, Pittman DL, Williams AJ. et al. Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay Performance. Clin Chem 2019; 65: 1141-1152
• 27 Peter A, Fritsche A, Stefan N. et al. Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes 2011; 119: 234-237
• 28 Keutmann S, Zylla S, Dahl M. et al. Measurement Uncertainty Impacts Diagnosis of Diabetes Mellitus: Reliable Minimal Difference of Plasma Glucose Results. Diabetes Ther 2020; 11: 293-303
• 29 Taboulet P, Deconinck N, Thurel A. et al. Correlation between urine ketones (acetoacetate) and capillary blood ketones (3-beta-hydroxybutyrate) in hyperglycaemic patients. Diabetes Metab 2007; 33: 135-139
• 30 Glaser N, Fritsch M, Priyambada L. et al. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes 2022; 23: 835-856
• 31 Thaler M, Roos M, Petersmann A. et al. Auto-Antikörper-Diagnostik in der Diabetologie – Aktueller Stand der Analytik und klinische Anwendung in Deutschland. Diabetol und Stoffwechs 2022; 17: 382-388
• 32 Hörber S, Achenbach P, Schleicher E. et al. Harmonization of immunoassays for biomarkers in diabetes mellitus. Biotechnology Advances 2020; 39: 107359
• 33 Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 2013; 30: 803-817
• 34 Fritsche A, Heni M, Peter A. et al. Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications. Exp Clin Endocrinol Diabetes 2022; 130: 200-204
• 35 Matthews DR, Hosker JP, Rudenski AS. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
• 36 Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495
• 37 Zavaroni I, Deferrari G, Lugari R. et al. Renal metabolism of C-peptide in man. J Clin Endocrinol Metab 1987; 65: 494-498
• 38 Bonser AM, Garcia-Webb P. C-peptide measurement: methods and clinical utility. Crit Rev Clin Lab Sci 1984; 19: 297-352
• 39 Alemán-Contreras R, Gómez-Díaz RA, Noyola-García ME. et al. Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA. Life (Basel) 2024; 14
• 40 D'Elia JA, Mulla C, Liu J. et al. Variations in glucose/C-peptide ratio in patients with type 2 diabetes associated with renal function. Diabetes Res Clin Pract 2019; 150: 1-7
• 41 Holt RIG, DeVries JH, Hess-Fischl A. et al. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2021; 44: 2589-2625
• 42 Insel RA, Dunne JL, Atkinson MA. et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 2015; 38: 1964-1974
• 43 Bojunga J, Schlereth F. Diabetes mellitus Typ 3c – Prävalenz, Diagnose, Besonderheiten der Therapie. Der Diabetologe 2018; 14: 269-277
• 44 Buzzetti R, Zampetti S, Maddaloni E. Adult-onset autoimmune diabetes: current knowledge and implications for management. Nat Rev Endocrinol 2017; 13: 674-686
• 45 Sims EK, Besser REJ, Dayan C. et al. Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective. Diabetes 2022; 71: 610-623
• 46 Leslie RD, Evans-Molina C, Freund-Brown J. et al. Adult-Onset Type 1 Diabetes: Current Understanding and Challenges. Diabetes Care 2021; 44: 2449-2456
• 47 Harding JL, Wander PL, Zhang X. et al. The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions. Diabetes Care 2022; 45: 994-1006
• 48 Besser REJ, Bell KJ, Couper JJ. et al. ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents. Pediatr Diabetes 2022; 23: 1175-1187
• 49 Kufeldt J, Kovarova M, Adolph M. et al. Prevalence and Distribution of Diabetes Mellitus in a Maximum Care Hospital: Urgent Need for HbA_1c-Screening. Exp Clin Endocrinol Diabetes 2018; 126: 123-129
• 50 Ahlqvist E, Storm P, Käräjämäki A. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018; 6: 361-369
• 51 Wagner R, Heni M, Tabák AG. et al. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat Med 2021; 27: 49-57
• 52 Herder C, Roden M. A novel diabetes typology: towards precision diabetology from pathogenesis to treatment. Diabetologia 2022; 65: 1770-1781
• 53 Misra S, Wagner R, Ozkan B. et al. Precision subclassification of type 2 diabetes: a systematic review. Commun Med (Lond) 2023; 3: 138
• 54 Jagannathan R, Neves JS, Dorcely B. et al. The Oral Glucose Tolerance Test: 100 Years Later. Diabetes Metab Syndr Obes 2020; 13: 3787-3805
• 55 Bergman M, Manco M, Satman I. et al. International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes. Diabetes Res Clin Pract 2024; 209: 111589
• 56 Ahuja V, Aronen P, Pramodkumar TA. et al. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021; 44: 1062-1069
• 57 Kirigin Bilos LS, Altabas V, Vukic Dugac A. et al. The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis. Medicina (Kaunas) 2024; 60: 477
• 58 Fritsche A. Insulin Secretion Capacity as a Crucial Feature to Distinguish Type 1 From Type 2 Diabetes and to Indicate the Need for Insulin Therapy – A Critical Discussion of the ADA/EASD Consensus Statement on the Management of Type 1 Diabetes in Adults. Exp Clin Endocrinol Diabetes 2023; 131: 500-503
• 59 Israel A, Raz I, Vinker S. et al. Type 2 Diabetes in Patients with G6PD Deficiency. N Engl J Med 2024; 391: 568-569